证券记录 · 已归档季度
MDXG
MiMedx Group, Inc. · Healthcare · Biotechnology
13被追踪持有人
-1Δ持有人
11.80M持有股份
$89.67M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -7.1% ·
股份流向 +3.3% ·
净新建仓位 -7.7%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 0 | 52.35M | $201.57M | +8 | −8 |
| Q1 2026 | 93 | 0 | 53.34M | $210.99M | +4 | −4 |
| Q4 2025 | 93 | +1 | 51.21M | $346.71M | +1 | — |
| Q3 2025 | 19 | 0 | 33.28M | $232.30M | — | — |
| Q2 2025 | 16 | 0 | 31.16M | $190.41M | +1 | −1 |
| Q1 2025 | 13 | -1 | 11.80M | $89.67M | — | −1 |
| Q4 2024 | 14 | +1 | 11.42M | $109.89M | +1 | — |
| Q3 2024 | 12 | -2 | 7.09M | $41.90M | — | −2 |
| Q2 2024 | 14 | — | 7.86M | $54.46M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 3.46M | +5.8% | $26.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 2.91M | +4.8% | $22.14M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 2.91M | +4.8% | $22.14M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 1.93M | +7.0% | $14.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.23M | +93.9% | $9.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 606.57K | +149.7% | $4.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 606.57K | +149.7% | $4.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 446.01K | 0.0% | $3.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 446.01K | 0.0% | $3.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 376.41K | -3.4% | $2.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 376.41K | -3.4% | $2.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 376.41K | -3.4% | $2.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 376.41K | -3.4% | $2.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 324.84K | -17.9% | $2.47M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 273.00K | 0.0% | $2.07M | 0.0% | Held | 4 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 101.26K | -72.1% | $769,584 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Norges Bank ✦ (被动) | 70.40K | -83.2% | $535,040 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 51.18K | +10.2% | $389,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 14.37K | +42.6% | $109,242 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 14.37K | +42.6% | $109,242 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 14.37K | +42.6% | $109,242 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 14.37K | +42.6% | $109,242 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $3.35M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 234 持有人, 112.82M 股份, $439.18M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据